Back to Screener

Leonardo DRS, Inc. - Common Stock (DRS)

NASDAQ Large Cap

Healthcare › Search, Detection, Navigation, Guidance, Aeronautical Sys

$45.35
Market Cap: $12.1B
Data as of Jun 30, 2026 (TTM)

Price History

Feb 9, 2026 — Aug 22, 2026

Investment Snapshot

  • Trading 191% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 7/9 — financially strong with improving fundamentals
  • ROE of 9.8% — below-average profitability
  • Revenue growing at 13% annually

Leonardo DRS, Inc. - Common Stock (DRS) is a Healthcare company operating in Search, Detection, Navigation, Guidance, Aeronautical Sys, listed on the NASDAQ , with a market capitalisation of $12.1 billion . Key value metrics: P/E ratio 44.2, P/B ratio 4.32, Piotroski F-Score 7 out of 9 (strong financial health) .

Value Score

Key Metrics

P/E Ratio
44.17
4.32
EPS
$1.03
Div. Yield
0.8%
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Leonardo DRS, Inc. - Common Stock — Fundamental Analysis Summary

Leonardo DRS, Inc. - Common Stock (DRS) is currently trading 191% above its Graham Number of $15.58, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 44.2x.

On financial health, DRS shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 9.8% (sector average: -20.1%), and minimal leverage with a debt-to-equity ratio of 0.05.

StockPik's composite Value Score for DRS is 67/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

DRS reports a moderate gross margin of 24.5% (sector average: 37.4%) and a modest operating margin of 9.6%.

DRS shows revenue growing at 13% year-over-year, with earnings growing at 31%.

DRS pays a modest dividend yield of 0.8%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
CGEN $2.28 6.1 100
ABEO $5.99 5.2 100
GMAB $33.45 2.2 100
EMBC $3.29 1.7 100
CRMD $8.75 3.5 100
High Piotroski F-Score stocks
Other stocks with F-Score ≥ 7 showing broad financial improvement
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
DRMA
Next
DRTS